Spectral AI Future Growth
Future criteria checks 0/6
Spectral AI's earnings are forecast to decline at 13.2% per annum while its annual revenue is expected to grow at 2.1% per year. EPS is expected to decline by 6.3% per annum.
Key information
-13.2%
Earnings growth rate
-6.31%
EPS growth rate
| Medical Equipment earnings growth | 16.1% |
| Revenue growth rate | 2.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 May 2026 |
Recent future growth updates
Recent updates
Analysis Article • May 15
Analyst Estimates: Here's What Brokers Think Of Spectral AI, Inc. (NASDAQ:MDAI) After Its First-Quarter Report
The analysts might have been a bit too bullish on Spectral AI, Inc. ( NASDAQ:MDAI ), given that the company fell short...
Narrative Update • May 08
MDAI: BARDA Funding And New Leadership Will Support Future Burn Preparedness
Analysts have trimmed their price target on Spectral AI to $6.00, reflecting slightly lower profit margin assumptions and a higher forward P/E multiple, even though their fair value estimate remains at $6.00 and discount rate expectations have eased. What's in the News Spectral AI received $31.7 million in immediate, non dilutive funding from the Biomedical Advanced Research and Development Authority to support additional feature development for its DeepView System, alongside a commitment from the company to contribute $9.7 million to total development costs (BARDA contract 75A50123C00049).
Narrative Update • Apr 21
MDAI: BARDA Funding And New Leadership Will Support Future Commercialization Potential
Analysts have updated their price targets on Spectral AI to reflect revised assumptions for discount rates, revenue growth, profit margins, and a higher forward P/E. These changes have resulted in a revised assessment of the potential upside in the shares.Narrative Update • Apr 06
MDAI: BARDA Funding And Leadership Transition Will Support Future Burn Preparedness
Analysts have nudged their Spectral AI price target to $6.00, citing small adjustments to assumptions on discount rate, revenue trends, profit margins, and a very high future P/E multiple as key drivers of the updated view. What's in the News Spectral AI received $31.7 million in immediate, non dilutive funding from the Biomedical Advanced Research and Development Authority to support additional feature development for its DeepView System, an AI driven burn wound imaging technology, alongside a company commitment of $9.7 million to total development costs (BARDA contract 75A50123C00049).Analysis Article • Mar 27
News Flash: Analysts Just Made A Stunning Upgrade To Their Spectral AI, Inc. (NASDAQ:MDAI) Forecasts
Shareholders in Spectral AI, Inc. ( NASDAQ:MDAI ) may be thrilled to learn that the analysts have just delivered a...Narrative Update • Mar 23
MDAI: BARDA Funding Will Support Future Burn Preparedness Commercialization Potential
Analysts have trimmed their price target on Spectral AI from $7.45 to $6.00 as they now apply a higher discount rate, expect a 28.16% decline in revenue growth, see profit margins at 12.86%, and use a much higher forward P/E multiple of 254.14x in their models. What's in the News Spectral AI received $31.7 million in immediate, non-dilutive funding from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to accelerate additional features for its DeepView System, with the company committing a further $9.7 million of its own capital to the project (Key Developments).Narrative Update • Mar 09
MDAI: New CEO Appointment Will Support Future Margin Recovery Potential
Analysts have trimmed their Spectral AI price target to $3.00, citing slightly higher discount rates, softer revenue growth expectations, a lower projected profit margin, and a higher assumed future P/E multiple in their updated model. What's in the News Spectral AI appointed Vincent S.Narrative Update • Feb 23
MDAI: Leadership Transition And Commercialization Progress Will Support Future Margin Recovery
Narrative Update on Spectral AI Analysts have kept their Spectral AI price target steady at $3.00, with unchanged fair value assumptions and only small tweaks to the discount rate, revenue growth, profit margin, and future P/E inputs. These adjustments support a largely unchanged outlook.
New Narrative • Feb 14
Spectral AI: First of Its Kind Automated Wound Healing Prediction
Overview Spectral AI is an artificial intelligence business offering predictive wound diagnostics designed to facilitate faster and more accurate treatment decisions in wound care. Spectral’s shares are traded as NASDAQ: MDAI.Narrative Update • Feb 07
MDAI: Contract Timing Shift Will Support Future Margin Recovery And Revenue Upside
Analysts have adjusted their price target on Spectral AI to reflect a slightly lower discount rate, a small change in expected revenue contraction, and an updated future P/E of about 86x, while keeping fair value steady at US$3.00. What's in the News Spectral AI revised its earnings guidance for fiscal year 2025, reducing expected revenue guidance from US$21.5 million to US$18.5 million.Analysis Article • Jan 27
Spectral AI, Inc. (NASDAQ:MDAI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders are no doubt pleased to see that the share price has bounced 29% in the...Narrative Update • Jan 23
MDAI: Contract Timing Shift Will Support Future Margin And Revenue Upside
Analysts now estimate Spectral AI's fair value at US$3.00 per share, unchanged from the prior US$3.00 view, as minor adjustments to the discount rate, revenue outlook, profit margin and future P/E assumptions leave their overall price target the same. What's in the News Spectral AI revised its revenue guidance for fiscal 2025 to US$18.5 million from US$21.5 million, reflecting updated expectations for the year (company guidance).Narrative Update • Jan 08
MDAI: Future Contract Timing Shift Will Support Stronger Profit Margins
Analysts have trimmed their price targets on Spectral AI to US$3.00, pointing to updated assumptions that include a slightly higher discount rate, a smaller revenue decline, a higher profit margin outlook, and a lower future P/E multiple of about 88x. What's in the News Spectral AI reduced its revenue guidance for fiscal 2025 from US$21.5 million to US$18.5 million, citing timing of work on its BARDA contract and effects from the current US government shutdown (Key Developments).Narrative Update • Dec 14
MDAI Future Revenue Shift From Contracts Will Support Stronger Profit Margins
Analysts have trimmed their price target on Spectral AI to reflect a modestly lower fair value estimate of 3.0 dollars from 3.5 dollars. They cited slightly higher perceived risk, even as outlooks improve for revenue contraction and profit margins, along with a marginally more attractive future earnings multiple.Analysis Article • Nov 28
Spectral AI, Inc. (NASDAQ:MDAI) Shares Could Be 26% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Spectral AI fair value estimate is US$2.14 Current share price...Analysis Article • Nov 28
The Market Doesn't Like What It Sees From Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Yet As Shares Tumble 27%
Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders won't be pleased to see that the share price has had a very rough month...Analysis Article • Oct 23
At US$2.24, Is Spectral AI, Inc. (NASDAQ:MDAI) Worth Looking At Closely?
Spectral AI, Inc. ( NASDAQ:MDAI ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...Analysis Article • Sep 06
Market Cool On Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Pushing Shares 25% Lower
Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders won't be pleased to see that the share price has had a very rough month...Analysis Article • Aug 16
Spectral AI, Inc. (NASDAQ:MDAI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.09
NasdaqCM:MDAI 1 Year Share Price vs Fair Value Explore Spectral AI's Fair Values from the Community and select yours...Analysis Article • Jul 29
Estimating The Intrinsic Value Of Spectral AI, Inc. (NASDAQ:MDAI)
Key Insights The projected fair value for Spectral AI is US$2.91 based on 2 Stage Free Cash Flow to Equity Spectral...Analysis Article • Jun 22
The Market Lifts Spectral AI, Inc. (NASDAQ:MDAI) Shares 50% But It Can Do More
Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders have had their patience rewarded with a 50% share price jump in the last...Analysis Article • Jun 22
The Market Lifts Spectral AI, Inc. (NASDAQ:MDAI) Shares 50% But It Can Do More
The Spectral AI, Inc. ( NASDAQ:MDAI ) share price has done very well over the last month, posting an excellent gain of...
New Narrative • May 06
FDA Submission Success Will Advance DeepView Global Opportunities
Successful burn validation study and international expansion strengthen FDA submission, potentially accelerating approval and driving future revenue growth.Analysis Article • Mar 08
Take Care Before Jumping Onto Spectral AI, Inc. (NASDAQ:MDAI) Even Though It's 28% Cheaper
Spectral AI, Inc. ( NASDAQ:MDAI ) shareholders that were waiting for something to happen have been dealt a blow with a...Analysis Article • Feb 10
Estimating The Intrinsic Value Of Spectral AI, Inc. (NASDAQ:MDAI)
Key Insights Spectral AI's estimated fair value is US$2.15 based on 2 Stage Free Cash Flow to Equity With US$2.06 share...Analysis Article • Dec 18
Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 39% Price Jump
Despite an already strong run, Spectral AI, Inc. ( NASDAQ:MDAI ) shares have been powering on, with a gain of 39% in...Analysis Article • Nov 03
Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump
Those holding Spectral AI, Inc. ( NASDAQ:MDAI ) shares would be relieved that the share price has rebounded 43% in the...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 25 | -21 | N/A | N/A | 2 |
| 12/31/2027 | 23 | -19 | N/A | N/A | 3 |
| 12/31/2026 | 19 | -18 | N/A | N/A | 3 |
| 3/31/2026 | 17 | -14 | -12 | -12 | N/A |
| 12/31/2025 | 20 | -8 | -10 | -10 | N/A |
| 9/30/2025 | 23 | -16 | -7 | -7 | N/A |
| 6/30/2025 | 28 | -14 | -6 | -6 | N/A |
| 3/31/2025 | 30 | -9 | -8 | -8 | N/A |
| 12/31/2024 | 30 | -15 | -9 | -9 | N/A |
| 9/30/2024 | 27 | -11 | -12 | -12 | N/A |
| 6/30/2024 | 23 | -20 | -16 | -16 | N/A |
| 3/31/2024 | 19 | -20 | -12 | -12 | N/A |
| 12/31/2023 | 18 | -21 | -13 | -13 | N/A |
| 9/30/2023 | 19 | -19 | -11 | -11 | N/A |
| 6/30/2023 | 22 | -9 | -7 | -7 | N/A |
| 3/31/2023 | 25 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 25 | -3 | -1 | -1 | N/A |
| 9/30/2022 | 23 | -3 | -2 | -2 | N/A |
| 6/30/2022 | 20 | -4 | -2 | -2 | N/A |
| 3/31/2022 | 18 | -5 | -3 | -3 | N/A |
| 12/31/2021 | 15 | -5 | -3 | -3 | N/A |
| 9/30/2021 | 16 | -4 | 0 | 0 | N/A |
| 6/30/2021 | 17 | -3 | 2 | 2 | N/A |
| 3/31/2021 | 17 | -1 | 3 | 3 | N/A |
| 12/31/2020 | 17 | 1 | 4 | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDAI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MDAI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MDAI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MDAI's revenue (2.1% per year) is forecast to grow slower than the US market (11.7% per year).
High Growth Revenue: MDAI's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MDAI's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/22 21:28 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Spectral AI, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Carl Byrnes | Northland Capital Markets |
| Vadim Alexandre Khalil | SP Angel Corporate Finance LLP |